Carlos A.M. Campos

Showing 1-10 of 10 articles

Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores

Janella B, Campos C, Caixeta A, Almeida B, Sandoli de Brito Jr F, Abizaid A, Perin M

November 20, 2017 | 10.4244/EIJ-D-16-00659

Interventions for valvular disease

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

Tateishi H, Abdelghani M, Cavalcante R, Miyazaki Y, Campos C, Collet C, Slots T, Leite R, Mangione J, Abizaid A, Soliman O, Spitzer E, Onuma Y, Serruys P, Lemos P, de Brito Jr F

May 15, 2017 | 10.4244/EIJ-D-16-00647

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Interventions for valvular disease

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry

Tateishi H, Campos C, Abdelghani M, Leite R, Mangione J, Bary L, Soliman O, Spitzer E, Perin M, Onuma Y, Serruys P, Lemos P, Brito F

March 18, 2016 | 10.4244/EIJV11I12A271

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

Généreux P, Campos C, Yadav M, Palmerini T, Caixeta A, Xu K, Francese D, Dangas G, Mehran R, Leon M, Serruys P, Stone G

October 20, 2015 | 10.4244/EIJY14M10_05

Coronary interventions

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

Campos C, Christiansen E, Stone G, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA26

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial

Ribeiro E, Campos C, Ribeiro H, Lopes A, Esper R, Meireles G, Perin M, Abizaid A, Lemos P

April 22, 2014 | 10.4244/EIJV9I12A234

Transcatheter aortic valve update 2013

Bourantas C, Van Mieghem N, Soliman O, Campos C, Iqbal J, Serruys P

September 15, 2013 | 10.4244/EIJV9SSA16

Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

Lemos P, Campos C, FalcÃ£o J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E

June 30, 2009 | 10.4244/EIJV5I2A37

Latest news

NEW ISSUE

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

AHEAD OF PRINT

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

AHEAD OF PRINT

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

EDITORIAL

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

EDITORIAL

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

EDITORIAL

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?